These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9158489)

  • 1. The tobacco industry and scientific publications. Findings of scientists who were and were not funded by tobacco industry were strikingly different.
    Whidden P
    BMJ; 1997 May; 314(7090):1350-1. PubMed ID: 9158489
    [No Abstract]   [Full Text] [Related]  

  • 2. The tobacco industry and scientific publications. Challenges on grounds of self evident potential bias are not unfair.
    Hedley AJ
    BMJ; 1997 May; 314(7090):1350. PubMed ID: 9158488
    [No Abstract]   [Full Text] [Related]  

  • 3. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco industry sponsorship of a book and conflict of interest.
    Hong MK; Bero LA
    Addiction; 2006 Aug; 101(8):1202-11. PubMed ID: 16869850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference?
    Turner C; Spilich GJ
    Addiction; 1997 Nov; 92(11):1423-6. PubMed ID: 9519485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco research funded by the tobacco industry--an ethical conflict.
    Bolinder G
    Addiction; 1997 Sep; 92(9):1071-5. PubMed ID: 9374002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japanese spousal smoking study revisited: how a tobacco industry funded paper reached erroneous conclusions.
    Yano E
    Tob Control; 2005 Aug; 14(4):227-33; discussion 233-5. PubMed ID: 16046682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins.
    Alasbali T; Smith M; Geffen N; Trope GE; Flanagan JG; Jin Y; Buys YM
    Am J Ophthalmol; 2009 Jan; 147(1):33-38.e2. PubMed ID: 18760766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease.
    Tong EK; Glantz SA
    Circulation; 2007 Oct; 116(16):1845-54. PubMed ID: 17938301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific analysis of second-hand smoke by the tobacco industry, 1929-1972.
    Schick S; Glantz S
    Nicotine Tob Res; 2005 Aug; 7(4):591-612. PubMed ID: 16085530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO says tobacco industry "used" institute to undermine its policies.
    MacDonald R
    BMJ; 2001 Mar; 322(7286):576. PubMed ID: 11238148
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethics. Is tobacco research turning over a new leaf?
    Grimm D
    Science; 2005 Jan; 307(5706):36-7. PubMed ID: 15637251
    [No Abstract]   [Full Text] [Related]  

  • 14. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases?
    Liyanage SS; Raina Macintyre C
    Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Naivety of researchers' and physicians' contacts with tobacco industry. Only a few are aware of the manipulation they are exposed to by well-conducted campaigns].
    Pershagen G
    Lakartidningen; 2002 Jun; 99(24):2726-8. PubMed ID: 12101596
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding tobacco use in Minnesota: findings from the ClearWay Minnesota research program.
    Schillo BA; Willoughby DJ
    Nicotine Tob Res; 2007 Jan; 9 Suppl 1():S7-9. PubMed ID: 17365721
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of strategic funding by the tobacco industry of medical expert witnesses appearing for the defence in the Aho Finnish product liability case.
    Hiilamo HT
    Addiction; 2007 Jun; 102(6):979-88. PubMed ID: 17523993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endotoxins in tobacco smoke: shifting tobacco industry positions.
    Barnes RL; Glantz SA
    Nicotine Tob Res; 2007 Oct; 9(10):995-1004. PubMed ID: 17852769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'It's interesting how few people die from smoking': tobacco industry efforts to minimize risk and discredit health promotion.
    Smith EA
    Eur J Public Health; 2007 Apr; 17(2):162-70. PubMed ID: 16837518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cigarette controversy.
    Cummings KM; Brown A; O'Connor R
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1070-6. PubMed ID: 17548665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.